tiprankstipranks
Advertisement

IPO - ETF AI Analysis

Compare

Top Page

IPO

Renaissance IPO ETF (IPO)

Rating:60Neutral
Price Target:
IPO, the Renaissance IPO ETF, has a solid but not outstanding overall rating, reflecting a mix of strong growth stories and meaningful risks among its largest positions. Heavily weighted holdings like ARM and Astera Labs support the fund’s quality through robust growth and strategic positioning, while names like Reddit and Kenvue add further strength with solid financial performance and important corporate moves. However, weaker holdings such as CoreWeave and Rubrik, which face financial instability and profitability challenges, along with the fund’s focus on newer, often richly valued companies, introduce higher risk and help explain why the rating is not higher.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the past month, indicating positive recent momentum.
Leading Winners in Top Holdings
Several of the largest positions, including CoreWeave, ARM, Astera Labs, CAVA, and others, have delivered strong gains, helping drive the fund’s returns.
Broad Sector Diversification
Holdings spread across technology, consumer, health care, industrials, real estate, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which can eat into long-term returns compared with lower-cost options.
Concentrated in a Few Names
A small number of stocks make up a large share of the portfolio, increasing the risk that problems at one or two companies could significantly affect performance.
Heavy U.S. and Technology Focus
With almost all assets in U.S. stocks and a large tilt toward technology, the ETF is sensitive to downturns in the U.S. market and the tech sector, and it offers little international diversification.

IPO vs. SPDR S&P 500 ETF (SPY)

IPO Summary

The Renaissance IPO ETF (ticker: IPO) tracks the FTSE Renaissance IPO Index, which focuses on newly public U.S. companies that have recently gone through an initial public offering (IPO). It holds a mix of fast-growing businesses across technology, consumer, and health care, including well-known names like ARM Holdings and Reddit. Investors might consider this ETF if they want an easy way to bet on the growth potential of new, innovative companies without picking individual IPO stocks. However, because it focuses on newer companies, the share price can be very volatile and may go up and down more than the overall market.
How much will it cost me?The Renaissance IPO ETF has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than the average for ETFs because it is actively managed, focusing on newly public companies that require more research and oversight. Active management typically leads to higher costs compared to passively managed funds that track broader indexes.
What would affect this ETF?The Renaissance IPO ETF could benefit from strong performance in the technology sector, which makes up nearly half of its holdings, as well as increased investor interest in innovative companies going public. However, it may face challenges if economic conditions worsen, leading to fewer IPOs or reduced investor appetite for high-growth but riskier stocks. Regulatory changes or market volatility could also negatively impact newly public companies in its portfolio.

IPO Top 10 Holdings

This IPO-focused ETF is riding a powerful wave of U.S. tech newcomers, with Astera Labs, CoreWeave, and ARM doing most of the heavy lifting as they benefit from the AI and cloud boom. Their rising share prices give the fund a clear tilt toward high-growth, chip-and-infrastructure names. On the flip side, Medline and Circle have been lagging, acting like a bit of sand in the ETF’s gears, while Reddit’s mixed performance adds some bumpiness. Overall, it’s a tech-heavy, U.S.-centric bet on freshly public innovators.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Astera Labs, Inc.10.71%$18.80M$69.66B368.84%
68
Neutral
ARM Holdings PLC ADR8.01%$14.06M$335.46B119.39%
69
Neutral
CoreWeave7.86%$13.81M$44.60B-42.91%
51
Neutral
Reddit Inc Class A7.54%$13.25M$37.48B37.61%
75
Outperform
Medline5.63%$9.88M$56.74B
Viking Holdings5.18%$9.10M$44.92B82.39%
66
Neutral
Rubrik, Inc. Class A3.77%$6.61M$17.22B0.56%
50
Neutral
Circle Internet Group, Inc. Class A3.36%$5.89M$16.06B-66.48%
64
Neutral
BrightSpring Health Services, Inc.3.19%$5.61M$13.55B229.10%
67
Neutral
American Healthcare REIT, Inc.3.05%$5.36M$11.48B50.78%
64
Neutral

IPO Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
54.32
Positive
100DMA
49.39
Positive
200DMA
48.23
Positive
Market Momentum
MACD
0.92
Positive
RSI
54.12
Neutral
STOCH
45.39
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IPO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 57.52, equal to the 50-day MA of 54.32, and equal to the 200-day MA of 48.23, indicating a bullish trend. The MACD of 0.92 indicates Positive momentum. The RSI at 54.12 is Neutral, neither overbought nor oversold. The STOCH value of 45.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IPO.

IPO Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$169.37M0.60%
60
Neutral
$940.18M0.59%
69
Neutral
$936.56M0.15%
73
Outperform
$918.57M0.50%
76
Outperform
$876.23M1.30%
68
Neutral
$852.38M0.27%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IPO
Renaissance IPO ETF
57.57
13.66
31.11%
SYLD
Cambria Shareholder Yield ETF
FDMO
Fidelity Momentum Factor ETF
HLAL
Wahed FTSE USA Shariah ETF
ULTY
YieldMax Ultra Option Income Strategy ETF
AUSF
Global X Adaptive U.S. Factor ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement